|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||
| · | Continuing efforts with insurance carrier to cover the costs of the business interruption and any future adverse financial effects of the shutdown; |
| · | Continuing efforts to solicit investment in the Company in the form of private placements of common shares to accredited investors not to exceed the shares authorized; |
| · | Continuing efforts to solicit investment in the Company in the form of secured and unsecured debt; |
| · | Continue to optimize production of recently expanded existing manufacturing capabilities to increase product revenues; |
| · | Continuing to focus efforts on new business development opportunities to generate revenues and expand and diversify the customer base; |
| · | Continuing development of white gemstone material to expand our product offerings and enhance our product marketability; and |
| · | Continuing to explore strategic joint ventures and technology licensing agreements to expand Company revenue and cash flow. |
| | | June 30, 2016 | | June 30, 2015 | | ||
| Common stock options | | | 694,375 | | | 1,035,208 | |
| Warrants to purchase common stock | | | 1,039,825 | | | 3,028,045 | |
| Non-vested restricted stock | | | 1,885,000 | | | 985,000 | |
| | | June 30, 2016 | | March 31, 2016 | | ||
| Raw materials and supplies | | $ | 19,053 | | $ | 24,179 | |
| Work in process | | | 30,075 | | | 19,514 | |
| Finished goods | | | 141,527 | | | 174,809 | |
| Inventory reserve | | | (30,484) | | | (28,975) | |
| | | $ | 160,171 | | $ | 189,527 | |
| | | Years | |
| Machinery and equipment | | 3 to15 | |
| Furniture and fixtures | | 3 to10 | |
| Engineering equipment | | 5 to 12 | |
|
|||
|
|||
| | | | | June 30, | | March 31, | | ||
| | | Life | | 2016 | | 2016 | | ||
| Patents, gross | | 6.75 19.46 | | $ | 9,967,433 | | $ | 9,967,433 | |
| Accumulated amortization | | | | | (2,983,359) | | | (2,741,987) | |
| Net intangible assets | | | | $ | 6,984,074 | | $ | 7,225,446 | |
| Fiscal Year Ending | | | | |
| Nine months ending March 31, 2017 | | $ | 724,118 | |
| March 31, 2018 | | | 965,490 | |
| March 31, 2019 | | | 965,490 | |
| March 31, 2020 | | | 785,809 | |
| March 31, 2021 | | | 740,592 | |
| Thereafter | | | 2,802,575 | |
| Total | | $ | 6,984,074 | |
|
|||
|
|||
|
|||
| | | | | Weighted- | | Weighted-Average | | |||
| | | | | Average Exercise | | Remaining | | |||
| | | Warrants | | Price | | Contractual Term | | |||
| Warrants Outstanding April 1, 2016 | | | 957,295 | | $ | 0.71 | | | 1.38 | |
| Issued | | | 82,530 | | | 0.22 | | | 4.98 | |
| Exercised | | | | | | | | | | |
| Expired | | | | | | | | | | |
| Warrants Outstanding June 30, 2016 | | | 1,039,825 | | $ | 0.67 | | | 1.43 | |
|
|||
| Restricted Stock | | Shares | | |
| Restricted stock outstanding March 31, 2016 | | | 1,885,000 | |
| Granted | | | | |
| Vested | | | | |
| Expired/cancelled | | | | |
| Restricted stock outstanding June 30, 2016 | | | 1,885,000 | |
| | | | | Weighted- | | Weighted-Average | | |||
| | | | | Average Exercise | | Remaining | | |||
| Options | | Shares | | Price | | Contractual Term | | |||
| Employee options outstanding March 31, 2016 | | | 694,375 | | $ | 0.87 | | | 7.13 | |
| Granted | | | | | | | | | | |
| Exercised | | | | | | | | | | |
| Expired/cancelled | | | | | | | | | | |
| Employee options outstanding June 30, 2016 | | | 694,375 | | $ | 0.87 | | | 6.88 | |
| Exercisable at June 30, 2016 | | | 190,333 | | $ | 0.99 | | | 8.31 | |
| | | | | Weighted | | ||
| | | | | Average | | ||
| | | | | Grant-Date | | ||
| Non-vested Shares | | Shares | | Fair Value | | ||
| Non-vested at March 31, 2016 | | | 682,375 | | | 0.81 | |
| Granted | | | | | | | |
| Vested | | | (178,333) | | | 0.98 | |
| Expired/cancelled: non-vested | | | | | | | |
| Non-vested at June 30, 2016 | | | 504,042 | | $ | 0.75 | |
| | | | Options Outstanding | | Options Exercisable | | |||||||||||
| | | | | | Weighted Average | | | | | | | | |||||
| | | | | | Remaining | | Weighted | | | | Weighted | | |||||
| Exercise | | Number | | Contractual Life | | Average | | Number of | | Average | | ||||||
| Prices | | Outstanding | | (years) | | Exercise Price | | Shares | | Exercise Price | | ||||||
| $ | 1.03 | | | 535,000 | | | 8.86 | | $ | 1.03 | | | 178,333 | | $ | 1.03 | |
| $ | 0.33 | | | 159,375 | | | 0.24 | | | 0.33 | | | 12,000 | | | 0.33 | |
| | | | | 694,375 | | | 6.88 | | $ | 0.87 | | | 190,333 | | $ | 0.99 | |
|
|||
|
|||
|
|||
| Balance of ownership interest in joint venture at March 31,2016 | | $ | 48,271 | |
| Aggregate fiscal 2017 equity loss share of joint venture income | | | (20,369 | ) |
| Balance of ownership interest in joint venture at June 30, 2016 | | $ | 27,902 | |
| Cumulative recognized income on ownership interest in joint venture at June 30, 2016 | | $ | 26,902 | |
| Revenues | | $ | 7,111 | |
| Expenses | | | 47,849 | |
| Net loss | | $ | (40,738 | ) |
| | | | | |
| Total assets | | $ | 513,766 | |
| | | | | |
| Total liabilities | | $ | 457,962 | |
| Total partner capital | | | 55,804 | |
| Total liabilities and partner capital | | $ | 513,766 | |
|
|||
| · | Continuing efforts with insurance carrier to cover the costs of the business interruption and any future adverse financial effects of the shutdown; |
| · | Continuing efforts to solicit investment in the Company in the form of private placements of common shares to accredited investors not to exceed the shares authorized; |
| · | Continuing efforts to solicit investment in the Company in the form of secured and unsecured debt; |
| · | Continue to optimize production of recently expanded existing manufacturing capabilities to increase product revenues; |
| · | Continuing to focus efforts on new business development opportunities to generate revenues and expand and diversify the customer base; |
| · | Continuing development of white gemstone material to expand our product offerings and enhance our product marketability; and |
| · | Continuing to explore strategic joint ventures and technology licensing agreements to expand Company revenue and cash flow. |
| | | June 30, 2016 | | June 30, 2015 | | ||
| Common stock options | | | 694,375 | | | 1,035,208 | |
| Warrants to purchase common stock | | | 1,039,825 | | | 3,028,045 | |
| Non-vested restricted stock | | | 1,885,000 | | | 985,000 | |
| | | June 30, 2016 | | March 31, 2016 | | ||
| Raw materials and supplies | | $ | 19,053 | | $ | 24,179 | |
| Work in process | | | 30,075 | | | 19,514 | |
| Finished goods | | | 141,527 | | | 174,809 | |
| Inventory reserve | | | (30,484) | | | (28,975) | |
| | | $ | 160,171 | | $ | 189,527 | |
| | | Years | |
| Machinery and equipment | | 3 to15 | |
| Furniture and fixtures | | 3 to10 | |
| Engineering equipment | | 5 to 12 | |
|
|||
| | | June 30, 2016 | | June 30, 2015 | | ||
| Common stock options | | | 694,375 | | | 1,035,208 | |
| Warrants to purchase common stock | | | 1,039,825 | | | 3,028,045 | |
| Non-vested restricted stock | | | 1,885,000 | | | 985,000 | |
| | | June 30, 2016 | | March 31, 2016 | | ||
| Raw materials and supplies | | $ | 19,053 | | $ | 24,179 | |
| Work in process | | | 30,075 | | | 19,514 | |
| Finished goods | | | 141,527 | | | 174,809 | |
| Inventory reserve | | | (30,484) | | | (28,975) | |
| | | $ | 160,171 | | $ | 189,527 | |
| | | Years | |
| Machinery and equipment | | 3 to15 | |
| Furniture and fixtures | | 3 to10 | |
| Engineering equipment | | 5 to 12 | |
|
|||
| | | | | June 30, | | March 31, | | ||
| | | Life | | 2016 | | 2016 | | ||
| Patents, gross | | 6.75 19.46 | | $ | 9,967,433 | | $ | 9,967,433 | |
| Accumulated amortization | | | | | (2,983,359) | | | (2,741,987) | |
| Net intangible assets | | | | $ | 6,984,074 | | $ | 7,225,446 | |
| Fiscal Year Ending | | | | |
| Nine months ending March 31, 2017 | | $ | 724,118 | |
| March 31, 2018 | | | 965,490 | |
| March 31, 2019 | | | 965,490 | |
| March 31, 2020 | | | 785,809 | |
| March 31, 2021 | | | 740,592 | |
| Thereafter | | | 2,802,575 | |
| Total | | $ | 6,984,074 | |
|
|||
| | | | | Weighted- | | Weighted-Average | | |||
| | | | | Average Exercise | | Remaining | | |||
| | | Warrants | | Price | | Contractual Term | | |||
| Warrants Outstanding April 1, 2016 | | | 957,295 | | $ | 0.71 | | | 1.38 | |
| Issued | | | 82,530 | | | 0.22 | | | 4.98 | |
| Exercised | | | | | | | | | | |
| Expired | | | | | | | | | | |
| Warrants Outstanding June 30, 2016 | | | 1,039,825 | | $ | 0.67 | | | 1.43 | |
|
|||
| Restricted Stock | | Shares | | |
| Restricted stock outstanding March 31, 2016 | | | 1,885,000 | |
| Granted | | | | |
| Vested | | | | |
| Expired/cancelled | | | | |
| Restricted stock outstanding June 30, 2016 | | | 1,885,000 | |
| | | | | Weighted- | | Weighted-Average | | |||
| | | | | Average Exercise | | Remaining | | |||
| Options | | Shares | | Price | | Contractual Term | | |||
| Employee options outstanding March 31, 2016 | | | 694,375 | | $ | 0.87 | | | 7.13 | |
| Granted | | | | | | | | | | |
| Exercised | | | | | | | | | | |
| Expired/cancelled | | | | | | | | | | |
| Employee options outstanding June 30, 2016 | | | 694,375 | | $ | 0.87 | | | 6.88 | |
| Exercisable at June 30, 2016 | | | 190,333 | | $ | 0.99 | | | 8.31 | |
| | | | | Weighted | | ||
| | | | | Average | | ||
| | | | | Grant-Date | | ||
| Non-vested Shares | | Shares | | Fair Value | | ||
| Non-vested at March 31, 2016 | | | 682,375 | | | 0.81 | |
| Granted | | | | | | | |
| Vested | | | (178,333) | | | 0.98 | |
| Expired/cancelled: non-vested | | | | | | | |
| Non-vested at June 30, 2016 | | | 504,042 | | $ | 0.75 | |
| | | | Options Outstanding | | Options Exercisable | | |||||||||||
| | | | | | Weighted Average | | | | | | | | |||||
| | | | | | Remaining | | Weighted | | | | Weighted | | |||||
| Exercise | | Number | | Contractual Life | | Average | | Number of | | Average | | ||||||
| Prices | | Outstanding | | (years) | | Exercise Price | | Shares | | Exercise Price | | ||||||
| $ | 1.03 | | | 535,000 | | | 8.86 | | $ | 1.03 | | | 178,333 | | $ | 1.03 | |
| $ | 0.33 | | | 159,375 | | | 0.24 | | | 0.33 | | | 12,000 | | | 0.33 | |
| | | | | 694,375 | | | 6.88 | | $ | 0.87 | | | 190,333 | | $ | 0.99 | |
|
|||
| Balance of ownership interest in joint venture at March 31,2016 | | $ | 48,271 | |
| Aggregate fiscal 2017 equity loss share of joint venture income | | | (20,369 | ) |
| Balance of ownership interest in joint venture at June 30, 2016 | | $ | 27,902 | |
| Cumulative recognized income on ownership interest in joint venture at June 30, 2016 | | $ | 26,902 | |
| Revenues | | $ | 7,111 | |
| Expenses | | | 47,849 | |
| Net loss | | $ | (40,738 | ) |
| | | | | |
| Total assets | | $ | 513,766 | |
| | | | | |
| Total liabilities | | $ | 457,962 | |
| Total partner capital | | | 55,804 | |
| Total liabilities and partner capital | | $ | 513,766 | |
|
||||||||||||||||||
|
||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||